{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:39:11Z","timestamp":1792402751090,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1053\/j.semdp.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T21:55:25Z","timestamp":1687384525000},"page":"392-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom"],"prefix":"10.1053","volume":"40","author":[{"given":"Amrit","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeyinwa E.","family":"Obiorah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.semdp.2023.06.002_bib0001","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","article-title":"Lymphoma in adolescents and young adults","volume":"36","author":"Jaglowski","year":"2009","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","article-title":"Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum","volume":"2016","author":"Sandlund","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0003","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0004","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2018-02-778480","article-title":"Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective","volume":"132","author":"Dunleavy","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2023.06.002_bib0005","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Soci\u00e9t\u00e9 Fran\u00e7aise d'Oncologie P\u00e9diatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0006","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2010.33.3369","volume":"30","author":"Cairo","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1053\/j.semdp.2023.06.002_bib0007","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0008","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0010","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1038\/bcj.2012.8","article-title":"Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies","volume":"2","author":"El-Mallawany","year":"2012","journal-title":"Blood Cancer J"},{"issue":"197","key":"10.1053\/j.semdp.2023.06.002_bib0011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws in African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0012","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-airlie house, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"issue":"5673","key":"10.1053\/j.semdp.2023.06.002_bib0013","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/274756a0","article-title":"Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study","volume":"274","author":"de-Th\u00e9","year":"1978","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1182\/blood-2018-04-844472","article-title":"How I treat Burkitt lymphoma in children, adolescents, and young adults in sub-Saharan Africa","volume":"132","author":"Gopal","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0015","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s100249910052","article-title":"Work-up and diagnosis of pediatric non-Hodgkin's lymphomas","volume":"3","author":"Perkins","year":"2000","journal-title":"Pediatr Dev Pathol"},{"issue":"7","key":"10.1053\/j.semdp.2023.06.002_bib0016","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.24934","article-title":"Trimodal age-specific incidence patterns for Burkitt lymphoma in the United States, 1973-2005","volume":"126","author":"Mbulaiteye","year":"2010","journal-title":"Int J Cancer"},{"issue":"19","key":"10.1053\/j.semdp.2023.06.002_bib0017","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1002\/cncr.26001","article-title":"Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder","volume":"117","author":"Picarsic","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2023.06.002_bib0018","first-page":"11","article-title":"Burkitt lymphoma in adolescents and young adults: management challenges","volume":"8","author":"Dozzo","year":"2017","journal-title":"Adolesc Health Med Ther"},{"key":"10.1053\/j.semdp.2023.06.002_bib0019","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2016.09.006","article-title":"Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis","volume":"20","author":"Moormann","year":"2016","journal-title":"Curr Opin Virol"},{"issue":"5","key":"10.1053\/j.semdp.2023.06.002_bib0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cncr.21307","article-title":"Cytologic diagnosis of Burkitt lymphoma","volume":"105","author":"Troxell","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1053\/j.semdp.2023.06.002_bib0021","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.onc.1202468","article-title":"Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma","volume":"18","author":"Gerbitz","year":"1999","journal-title":"Oncogene"},{"issue":"8","key":"10.1053\/j.semdp.2023.06.002_bib0022","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1073\/pnas.85.8.2748","article-title":"Dalla-Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma","volume":"85","author":"Neri","year":"1988","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263980","article-title":"Cryptic MYC insertions in Burkitt lymphoma: new data and a review of the literature","volume":"17","author":"Woroniecka","year":"2022","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0024","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/gcc.22161","article-title":"Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples","volume":"53","author":"Maria Murga Penas","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0026","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0027","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt's Lymphoma","volume":"387","author":"Roschewski","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0028","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1038\/s41467-022-31355-8","article-title":"Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age","volume":"13","author":"Burkhardt","year":"2022","journal-title":"Nat Commun"},{"issue":"7530","key":"10.1053\/j.semdp.2023.06.002_bib0029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via G\u03b113 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"issue":"7418","key":"10.1053\/j.semdp.2023.06.002_bib0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1053\/j.semdp.2023.06.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic Burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS Pathog"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0032","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2023.06.002_bib0033","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic Burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"7","key":"10.1053\/j.semdp.2023.06.002_bib0034","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"9","key":"10.1053\/j.semdp.2023.06.002_bib0035","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1053\/j.semdp.2023.06.002_bib0036","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0037","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PAS.0000000000001613","article-title":"A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas","volume":"45","author":"Horn","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0038","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/PAS.0000000000001869","article-title":"Burkitt-like lymphoma with 11q aberration: a characteristic chromosomal alteration and a particular morphologic feature","volume":"46","author":"Horn","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0039","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"issue":"13","key":"10.1053\/j.semdp.2023.06.002_bib0040","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood-2013-01-475772","article-title":"Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma","volume":"122","author":"Bonetti","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0041","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.22014","article-title":"High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas","volume":"52","author":"Salaverria","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1053\/j.semdp.2023.06.002_bib0042","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2023.06.002_bib0043","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0044","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","article-title":"Recent advances in the understanding and management of diffuse large B-cell lymphoma in children","volume":"142","author":"Reiter","year":"2008","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0046","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3324\/haematol.2016.147116","article-title":"Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents","volume":"101","author":"Attarbaschi","year":"2016","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2023.06.002_bib0047","volume":"2017","author":"Nakamura","year":"2017"},{"issue":"10","key":"10.1053\/j.semdp.2023.06.002_bib0048","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","article-title":"Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial","volume":"107","author":"Oschlies","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0049","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21619","article-title":"Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: report of the French-American-British (FAB) international study group","volume":"51","author":"Miles","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1053\/j.semdp.2023.06.002_bib0050","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1182\/blood-2011-05-349662","article-title":"Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling","volume":"119","author":"Deffenbacher","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0051","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/cam4.3736","article-title":"Associations between race and survival in pediatric patients with diffuse large B-cell lymphoma","volume":"10","author":"Khullar","year":"2021","journal-title":"Cancer Med"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0052","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2016.09.004","article-title":"High grade B-cell lymphoma with rearrangements of MYC and BCL2 and\/or BCL6: double hit and triple hit lymphomas and double expressing lymphoma","volume":"31","author":"Rosenthal","year":"2017","journal-title":"Blood Rev"},{"issue":"5","key":"10.1053\/j.semdp.2023.06.002_bib0053","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0054","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PAS.0b013e31826cebad","article-title":"Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas","volume":"37","author":"Pillai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0055","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/PAS.0b013e3181bb9a18","article-title":"Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome","volume":"33","author":"Gualco","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"20","key":"10.1053\/j.semdp.2023.06.002_bib0056","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0057","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pathol.2019.09.008","article-title":"High-grade B-cell lymphoma: a term re-purposed in the revised WHO classification","volume":"52","author":"Ok","year":"2020","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2023.06.002_bib0058","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/asheducation-2008.1.349","article-title":"Primary mediastinal B-cell lymphoma","author":"Johnson","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0059","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood.2020007683","article-title":"Characterization of DLBCL with a PMBL gene expression signature","volume":"138","author":"Duns","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2023.06.002_bib0060","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/PAS.0000000000000473","article-title":"Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling","volume":"39","author":"Yuan","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.06.002_bib0061","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2018-04-791566","article-title":"How I treat primary mediastinal B-cell lymphoma","volume":"132","author":"Giulino-Roth","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2023.06.002_bib0062","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.critrevonc.2017.01.009","article-title":"Primary mediastinal large B-cell lymphoma","volume":"113","author":"Martelli","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1053\/j.semdp.2023.06.002_bib0063","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3324\/haematol.2021.280342","article-title":"Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance","volume":"107","author":"Fisher","year":"2022","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2023.06.002_bib0064","first-page":"22","article-title":"Pediatric mediastinal lymphoma","volume":"4","author":"Mallick","year":"2020","journal-title":"Mediastinum (Hong Kong, China)"},{"issue":"7338","key":"10.1053\/j.semdp.2023.06.002_bib0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0066","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2014-05-575092","article-title":"Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?","volume":"125","author":"Dunleavy","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0067","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"issue":"22","key":"10.1053\/j.semdp.2023.06.002_bib0068","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2023.06.002_bib0069","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2010.030809","article-title":"Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children","volume":"96","author":"Oschlies","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0071","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/2643-3230.BCD-20-0009","article-title":"Gene expression profiling of mediastinal gray zone lymphoma and its relationship to primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma","volume":"1","author":"Pittaluga","year":"2020","journal-title":"Blood Cancer Discovery"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0072","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/cncr.10396","article-title":"Massing BG. A population-based study of pediatric anaplastic large cell lymphoma","volume":"94","author":"Alessandri","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10040099","article-title":"Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond","volume":"10","author":"Prokoph","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0074","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I diagnose anaplastic large cell lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2023.06.002_bib0075","first-page":"2697","article-title":"ALK+ lymphoma: clinico-pathological findings and outcome","volume":"93","author":"Falini","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0076","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3960\/jslrt.17023","article-title":"Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects","volume":"57","author":"Tsuyama","year":"2017","journal-title":"J Clin Exp Hematop"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0077","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.semdp.2023.06.002_bib0078","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.semdp.2011.03.002","article-title":"Anaplastic large-cell lymphoma","volume":"28","author":"Inghirami","year":"2011","journal-title":"Semin Diagn Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0079","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","article-title":"Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T\/NK-cell lymphomas. A North American PTCL study group project","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.semdp.2023.06.002_bib0081","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2005.05808.x","article-title":"Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation: a genetic and pathological correlation","volume":"131","author":"Perkins","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0082","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1309\/TLE8FN6EYF0NJGP7","article-title":"Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma","volume":"121","author":"Liang","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0083","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/PAS.0000000000000500","article-title":"Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements","volume":"40","author":"King","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2023.06.002_bib0084","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0085","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"32","key":"10.1053\/j.semdp.2023.06.002_bib0086","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","article-title":"Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials","volume":"30","author":"Sibon","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178416","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma: clinico-pathological study of 17 cases with review of literature","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1053\/j.semdp.2023.06.002_bib0088","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000000753","article-title":"ALK-positive large B-cell lymphoma: a Clinicopathologic Study of 26 cases with review of additional 108 cases in the literature","volume":"41","author":"Pan","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0089","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.semdp.2023.06.002_bib0090","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/bjh.15764","article-title":"Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives","volume":"185","author":"Cairo","year":"2019","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.semdp.2023.06.002_bib0091","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bjh.14035","article-title":"Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science","volume":"173","author":"Cairo","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1053\/j.semdp.2023.06.002_bib0092","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.6004\/jnccn.2022.0057","article-title":"Pediatric aggressive mature B-cell lymphomas, Version 3.2022, NCCN Clinical practice guidelines in oncology","volume":"20","author":"Barth","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1053\/j.semdp.2023.06.002_bib0093","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2012-04-422709","article-title":"Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB\/LMB96 mature B-NHL therapy","volume":"121","author":"Gerrard","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.semdp.2023.06.002_bib0094","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1200\/JCO.2003.08.151","article-title":"Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-M\u00fcnster Group","volume":"21","author":"Seidemann","year":"2003","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0095","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.semdp.2023.06.002_bib0096","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":"Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257023000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:24:45Z","timestamp":1760037885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257023000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0740257023000722"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2023.06.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}